EFFECTS OF CO-TRIMOXAZOLE CO-ADMINISTRATION ON THE PHARMACOKINETICS OF AMODIAQUINE IN HEALTHY VOLUNTEERS
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2015, Vol 7, Issue 9
Abstract
Objectives: Amodiaquine (AQ) is a 4-aminoquinoline antimalarial drug that is rapidly and extensively metabolized mainly by CYP2C8 enzyme to N-desethylamodiaquine (DEAQ). Co-trimoxazole (CTZ) is a combination (sulfamethoxazole and trimethoprim) antimicrobial agent with the trimethoprim component being a potent inhibitor of CYP2C8. AQ and CTZ are likely to be co-administered in the treatment of patients with malaria and susceptible bacterial infections. This study evaluates the effect of CTZ co-administration on the pharmacokinetics of AQ. Methods: In an open, two-way crossover study, 16 healthy volunteers were randomized to receive 600 mg single oral dose of AQ with or without the eleventh dose of CTZ (960 mg every 12 h for 7 days.) Blood samples were collected at pre-determined time intervals and analyzed for AQ and its major metabolite, DEAQ using a validated HPLC method.Results: Co-administration of AQ and CTZ resulted in significant increases in the total area under the concentration–time curve (AUCT), maximum plasma concentration (Cmax) and terminal elimination half-life (T½) of AQ compared with values with AQ dosing alone (AUCT:234.36±57.21 vs 366.42±62.48 h ng/ml; Cmax:24.86±7.28 vs 40.28±11.15 ng/ml; T½: 6.49±3.56 vs 9.24±2.97 h), while the oral plasma clearance markedly decreased (3862.66±756.38 vs 2654.28±650.12 L/h). Co-administration also led to a pronounced decrease in the ratio of AUC(metabolite)/AUC (unchanged drug) and highly significant decreases in Cmax and AUC of the metabolite.Conclusion: Study evaluated for the first time the effect of CTZ co-administration on the pharmacokinetics of AQ in healthy adult volunteers. CTZ significantly increased AQ exposure and decreased plasma levels of the active metabolite DEAQ.Â
Authors and Affiliations
Ademisoye Adebusuyi Akande, Soyinka Julius Olugbenga, Adegbola Jonathan Adebanjo, Abdullahi Sa’ad Toyin, Onyeji Cyprian Ogbona
PHYSICOCHEMICAL, PRELIMINARY PHYTOCHEMICAL ANALYSIS AND ANTIBACTERIAL ACTIVITY AGAINST CLINICAL PATHOGENS OF MEDICINALLY IMPORTANT ORCHID GEODORUM DENSIFLORUM (LAM) SCHLTR
Objective: To evaluate the Physicochemical, Preliminary Phytochemical analysis and Antibacterial activity of Geodorum densiflorum against clinical pathogens and to prove the orchid will target to meet the therapeutic dem...
DESIGN, SYNTHESIS AND PRELIMINARY PHARMACOLOGICAL EVALUATION OF NEW METFORMIN DERIVATIVES
Objective: The purpose of this work was to enhance oral bioavailability of metformin by incorporation of different amino acid residues through the glycolic acid spacer.Methods: Two series of metformin derivatives (V a-e)...
ANTIBACTERIAL, ANTIOXIDANT AND ANTIPROLIFERATIVE ACTIVITIES OF SOLVENT EXTRACTS OF TILIACORA ACUMINATA
Objective: To study the antibacterial, antioxidant and anti proliferative activities of ethanol, methanol and ethyl acetate extracts of Tiliacora acuminata leavesMethods: Phytochemical tests were performed according to t...
ISOLATION AND CHARACTERIZATION OF ENDOPHYTIC FUNGI FROM MEDICINAL PLANT CRESCENTIA CUJETE L. AND THEIR ANTIBACTERIAL, ANTIOXIDANT AND ANTICANCER PROPERTIES
Objective: The present study was aimed to isolate endophytic fungi from ethano-medicinally important plant Crescentia cujete L. in view to screen their bioactive principles towards different pharmacological applications....
ANTIMICROBIAL, ANTIOXIDANT, CYTOTOXIC ACTIVITIES AND PHYTOCHEMICAL ASSESSMENT OF COLA ACUMINATA USED IN BENIN
Objective: The aim of this study was to make a phytochemical screening and measure some biological activities of Cola acuminata’s seeds and leaves extracts.Methods: The secondary metabolite was detected by the method b...